As a matter of fact, when combined, these drug regimens lead to GEC sensibilization to cytotoxic treatment, particularly in non-metastatic brain tumors; moreover, following radiotherapy, anti-VEGF treatment causes a significant decrease in the expression of VEGF in glioblastoma cells [43]. The gene discussed is VEGFA; the disease is brain neoplasm.